The 6 analysts offering 12-month price forecasts for ABIOMED Inc have a median target of 390.00, with a high estimate of 425.00 and a low estimate of 245.00. The median estimate represents a +24.98% increase from the last price of 312.06.
The current consensus among 10 polled investment analysts is to Buy stock in ABIOMED Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.05
Reporting Date Jul 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.